期刊文献+

DNA甲基化和组蛋白乙酰化修饰调控腹膜纤维化的研究进展 被引量:3

原文传递
导出
摘要 终末期肾脏病(end—stage renal disease,ESRD)已经成为全球性公共卫生健康问题。据统计中国约有10万例ESRD患者,且人数在逐年增长阁。目前ESRD的治疗方法主要包括血液透析、腹膜透析和肾移植。
出处 《中华肾脏病杂志》 CAS CSCD 北大核心 2016年第12期945-948,共4页 Chinese Journal of Nephrology
基金 国家自然基金(81670623、81670690、81470991、81470920、81270778) 上海市浦江人才项目(13PJ1406900) 浦东新区卫生系统重点学科建设基金(PWZx2014-06)
  • 相关文献

参考文献2

二级参考文献31

  • 1Stefania M, Emanuela M, Rosanna Di P, et al. Thalidomide suppresses selerosing encapsulating in a rat experimental model. Shock, 2009, 3: 332-339.
  • 2Saglam F, Cavdar Z, Sarioglu S, et al. Pioglitazone Reduces Peritoneal Fibrosis via Inhibition of TGF-β, MMP-2, and MMP- 9 in a model of encapsulating peritoneal sclerosis. Renal Failure, 2012, 34: 95-102.
  • 3Pletinck A, Vanholder R, Veys N, et al. Protecting the peritoneal membrane: factors beyond peritoneal dialysis solutions. Nat Rev Nephrol, 2012, 8: 542-550.
  • 4Stavenuiter AW, Schilte MN, Ter Wee PM, et al. Angiogenesis in peritoneal dialysis. Kidney Blood Press Res, 2011, 34: 245- 252.
  • 5Tomino Y. Mechanisms and interventions in peritoneal fibrosis. Clin Exp Nephrol, 2012, 16: 109-114.
  • 6Arai H, Furusu A, Nishino T. Thalidomide prevents the progression of peritoneal fibrosis in mice. Acta Histochem Cytochem, 2011, 44: 51-60.
  • 7Ertilav M, Hur E, Bozkurt D, et al. Octreotide lessens peritoneal injury in experimental encapsulated peritoneal sclerosis model. Nephrology (Carlton), 2011, 16: 552-557.
  • 8Ceri M, Unverdi S, Dogan M, et al. Duranay.Effect of sirolimus on the regression of peritoneal sclerosis in an experimental rat mode. Int Urol Nephrol, 2012, 44: 977-982.
  • 9Hur E, Bozkurt D, Timur O, et al. The effects of mycophenolate mofetil on encapsulated peritoneal sclerosis model in rats. Clin Nephrol, 2012, 77: 1-7.
  • 10Ha H, Lee HB. Effect of high glucose on peritoneal mesothelial cell biology. Petit Dial Int, 2000, 20 Suppl 2: S15-S18.

共引文献9

同被引文献33

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部